Showing 13 to 22 of 22 results
Veteran's Cancer Remission Highlights Immunotherapy Success
U.S. Navy veteran John Ryan, diagnosed with stage 4 lung cancer in 2013, achieved remission after 100 months of immunotherapy treatment, highlighting the effectiveness of this approach and the increased cancer risk among veterans.
Veteran's Cancer Remission Highlights Immunotherapy Success
U.S. Navy veteran John Ryan, diagnosed with stage 4 lung cancer in 2013, achieved remission after 100 months of immunotherapy treatment, highlighting the effectiveness of this approach and the increased cancer risk among veterans.
Progress
40% Bias Score
France Launches Pilot Program for Lung Cancer Screening
France is launching a 6 million euro pilot program involving 20,000 smokers/ex-smokers (50-74 years old) for lung cancer screening using low-dose CT scans and cessation support, aiming to inform nationwide screening by 2030.
France Launches Pilot Program for Lung Cancer Screening
France is launching a 6 million euro pilot program involving 20,000 smokers/ex-smokers (50-74 years old) for lung cancer screening using low-dose CT scans and cessation support, aiming to inform nationwide screening by 2030.
Progress
48% Bias Score
New Urine Test Detects Lung Cancer 'Zombie Cells'
British scientists created a new urine test to detect lung cancer earlier by identifying 'zombie cell' proteins; this non-invasive test, successful in mice, aims for human trials and could revolutionize early cancer detection.
New Urine Test Detects Lung Cancer 'Zombie Cells'
British scientists created a new urine test to detect lung cancer earlier by identifying 'zombie cell' proteins; this non-invasive test, successful in mice, aims for human trials and could revolutionize early cancer detection.
Progress
8% Bias Score
New Urine Test Detects Lung Cancer Earlier by Identifying 'Zombie Cells'
British scientists developed a new urine test detecting lung cancer earlier by finding "zombie cells," aiming for earlier diagnosis and treatment of the deadliest cancer globally, killing almost 227,000 in the EU in 2021.
New Urine Test Detects Lung Cancer Earlier by Identifying 'Zombie Cells'
British scientists developed a new urine test detecting lung cancer earlier by finding "zombie cells," aiming for earlier diagnosis and treatment of the deadliest cancer globally, killing almost 227,000 in the EU in 2021.
Progress
32% Bias Score
Lung Cancer Awareness in Turkey
A Turkish doctor highlights the alarming statistics of lung cancer in Turkey, emphasizing the risks of smoking, e-cigarettes, and environmental factors, along with the importance of early detection.
Lung Cancer Awareness in Turkey
A Turkish doctor highlights the alarming statistics of lung cancer in Turkey, emphasizing the risks of smoking, e-cigarettes, and environmental factors, along with the importance of early detection.
Progress
0% Bias Score
Lung Cancer Rise in Non-Smoking Women Linked to Air Pollution and Genetic Factors
A new study shows a sharp rise in lung cancer among non-smoking women globally, with adenocarcinoma accounting for almost 60% of cases, linked to air pollution, genetic mutations (EGFR, ALK, ROS1, TP53, KRAS), and immune system factors; approximately 2.5 million new cases were reported in 2022.
Lung Cancer Rise in Non-Smoking Women Linked to Air Pollution and Genetic Factors
A new study shows a sharp rise in lung cancer among non-smoking women globally, with adenocarcinoma accounting for almost 60% of cases, linked to air pollution, genetic mutations (EGFR, ALK, ROS1, TP53, KRAS), and immune system factors; approximately 2.5 million new cases were reported in 2022.
Progress
40% Bias Score
J&J's Lung Cancer Drug Extends Life by at Least a Year
Johnson & Johnson announced Tuesday that its two-drug lung cancer regimen, Rybrevant and Lazcluze, extends life expectancy by at least a year compared to AstraZeneca's Tagrisso, based on a pivotal trial, though the regimen has more side effects.
J&J's Lung Cancer Drug Extends Life by at Least a Year
Johnson & Johnson announced Tuesday that its two-drug lung cancer regimen, Rybrevant and Lazcluze, extends life expectancy by at least a year compared to AstraZeneca's Tagrisso, based on a pivotal trial, though the regimen has more side effects.
Progress
60% Bias Score
Urine Test Detects Lung Cancer Earlier Using \"Zombie Cells\"
British scientists created a urine test detecting lung cancer earlier by identifying \"zombie cells\"—senescent cells releasing proteins detected by an injectable sensor—which successfully identified early-stage lung cancer in rats, potentially revolutionizing cancer detection.
Urine Test Detects Lung Cancer Earlier Using \"Zombie Cells\"
British scientists created a urine test detecting lung cancer earlier by identifying \"zombie cells\"—senescent cells releasing proteins detected by an injectable sensor—which successfully identified early-stage lung cancer in rats, potentially revolutionizing cancer detection.
Progress
40% Bias Score
Peruvian Teen Saved by Innovative Lung Surgery in Turin
A 16-year-old Peruvian boy with a rare lung tumor was successfully treated in Turin, Italy, thanks to an innovative surgical procedure.
Peruvian Teen Saved by Innovative Lung Surgery in Turin
A 16-year-old Peruvian boy with a rare lung tumor was successfully treated in Turin, Italy, thanks to an innovative surgical procedure.
Progress
20% Bias Score
Back Pain: A Lung Cancer Symptom?
A former GP's unexpected lung cancer diagnosis highlights the importance of recognizing atypical symptoms like back pain. The Roy Castle Lung Cancer Foundation emphasizes that anyone can develop lung cancer.
Back Pain: A Lung Cancer Symptom?
A former GP's unexpected lung cancer diagnosis highlights the importance of recognizing atypical symptoms like back pain. The Roy Castle Lung Cancer Foundation emphasizes that anyone can develop lung cancer.
Progress
0% Bias Score
Showing 13 to 22 of 22 results